ebomi
Colour theme
Sign in
Insider · CIK 0001276551

Brancaccio John P

CIK 0001276551 Name as filed on the most recent filing

Filed as Brancaccio John P (13)

13 transaction lines · from 13 filings · filed 2006-07-24 to 2026-08-07 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

13 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-07-21 Okyo Pharma Ltd
OKYO 		P, Open-market purchase 5,000 acquired 1.48 7,385.00 Form 4, filing 0001493152-26-036585
2023-09-15 Okyo Pharma Ltd
OKYO 		P, Open-market purchase 16,670 acquired 1.50 25,005.00 Form 4, filing 0001493152-23-034486
2021-03-22 Cardiff Oncology, Inc.
CRDF 		P, Open-market purchase 3,000 acquired 10.95 32,850.00 Form 4, filing 0001628280-21-005297
2020-12-02 Hepion Pharmaceuticals, Inc.
HEPA 		P, Open-market purchase 7,000 acquired 1.53 10,710.00 Form 4, filing 0001104659-20-131656
2020-05-14 Cardiff Oncology, Inc.
CRDF 		P, Open-market purchase 6,993 acquired 1.43 9,999.99 Form 4, filing 0001104659-20-063179
2018-06-08 Trovagene, Inc.
TROV 		P, Open-market purchase 10,000 acquired 0.80 8,000.00 Form 4, filing 0000899243-18-016465
2018-06-08 Trovagene, Inc.
TROV 		P, Open-market purchase 10,000 acquired 0.80 8,000.00 Form 4, filing 0000899243-18-015836
2017-05-26 Synergy Pharmaceuticals, Inc.
SGYP 		P, Open-market purchase 6,500 acquired 3.59 23,335.00 Form 4, filing 0001104659-17-035885
2016-09-19 Synergy Pharmaceuticals, Inc.
SGYP 		S, Open-market sale 2,518 disposed 5.76 14,503.68 Form 4, filing 0001104659-16-145907
2014-06-03 Synergy Pharmaceuticals, Inc.
SGYP 		P, Open-market purchase 3,500 acquired 4.12 14,420.00 Form 4, filing 0001104659-14-043599
2014-03-04 ContraVir Pharmaceuticals, Inc.
CTRV 		P, Open-market purchase 4,393 acquired 1.49 6,545.57 Form 4, filing 0001104659-14-017252
2007-10-19 Alfacell Corp
ACEL 		P, Open-market purchase 2,300 acquired 1.94 4,462.00 Form 4, filing 0001005477-07-005392
2006-07-24 Alfacell Corp
ACEL 		P, Open-market purchase 4,000 acquired 2.05 8,200.00 Form 4, filing 0001005477-06-003610

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BRANCACCIO JOHN P, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001276551

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.